Lung cancer is the most frequently life-threatening disease and the prominent cause of cancer-related mortality among human beings worldwide, where poor early diagnosis and expensive detection costs are considered as significant reasons. Here, we try to tackle this issue by proposing a novel label-free and low-cost strategy for rapid detection and distinction of lung cancer cells relying on plasmonic toroidal metasurfaces at terahertz frequencies. Three disjoint regions are displayed in identifiable intensity-frequency diagram, which could directly help doctors determine the type of lung cancer cells for clinical treatment. The metasurface is generated by two mirrored gold split ring resonators with subwavelength sizes. When placing analytes on the metasurface, apparent shifts of both the resonance frequency and the resonance depth can be observed in the terahertz transmission spectra. The theoretical sensitivity of the biosensor over the reflective index reaches as high as 485.3 GHz/RIU. Moreover, the proposed metasurface shows high angular stability for oblique incident angle from 0 to 30°, where the maximum resonance frequency shift is less than 0.66% and the maximum transmittance variation keeps below 1.33%. To experimentally verify the sensing strategy, three types of non-small cell lung cancer cells (Calu-1, A427, and 95D) are cultured with different concentrations and their terahertz transmission spectra are measured with the proposed metasurface biosensor. The two-dimensional fingerprint diagram considering both the frequency and transmittance variations of the toroidal resonance dip is obtained, where the curves for different cells are completely separated with each other. This implies that we can directly distinguish the type of the analyte cells and its concentration by only single spectral measurement. We envisage that the proposed strategy has potential for clinical diagnosis and significantly expands the capabilities of plasmonic metamaterials in biological detection.
Background
Chest X-ray radiography (CXR) has been widely considered as an accessible, feasible, and convenient method to evaluate suspected patients’ lung involvement during the COVID-19 pandemic. However, with the escalating number of suspected cases, traditional diagnosis via CXR fails to deliver results within a short period of time. Therefore, it is crucial to employ artificial intelligence (AI) to enhance CXRs for obtaining quick and accurate diagnoses. Previous studies have reported the feasibility of utilizing deep learning methods to screen for COVID-19 using CXR and CT results. However, these models only use a single deep learning network for chest radiograph detection; the accuracy of this approach required further improvement.
Methods
In this study, we propose a three-step hybrid ensemble model, including a feature extractor, a feature selector, and a classifier. First, a pre-trained AlexNet with an improved structure extracts the original image features. Then, the ReliefF algorithm is adopted to sort the extracted features, and a trial-and-error approach is used to select the
n
most important features to reduce the feature dimension. Finally, an SVM classifier provides classification results based on the
n
selected features.
Results
Compared to five existing models (InceptionV3: 97.916 ± 0.408%; SqueezeNet: 97.189 ± 0.526%; VGG19: 96.520 ± 1.220%; ResNet50: 97.476 ± 0.513%; ResNet101: 98.241 ± 0.209%), the proposed model demonstrated the best performance in terms of overall accuracy rate (98.642 ± 0.398%). Additionally, compared to the existing models, the proposed model demonstrates a considerable improvement in classification time efficiency (SqueezeNet: 6.602 ± 0.001s; InceptionV3: 12.376 ± 0.002s; ResNet50: 10.952 ± 0.001s; ResNet101: 18.040 ± 0.002s; VGG19: 16.632 ± 0.002s; proposed model: 5.917 ± 0.001s).
Conclusion
The model proposed in this article is practical and effective, and can provide high-precision COVID-19 CXR detection. We demonstrated its suitability to aid medical professionals in distinguishing normal CXRs, viral pneumonia CXRs and COVID-19 CXRs efficiently on small sample sizes.
Purpose: Pulmonary nodules are a potential manifestation of lung cancer. In computer-aided diagnosis (CAD) of lung cancer, it is of great significance to extract the complete boundary of the pulmonary nodules in the computed tomography (CT) scans accurately. It can provide doctors with important information such as tumor size and density, which assist doctors in subsequent diagnosis and treatment. In addition to this, in the molecular subtype and radiomics of lung cancer, segmentation of lung nodules also plays a pivotal role. Existing methods are difficult to use only one model to simultaneously treat the boundaries of multiple types of lung nodules in CT images. Method: In order to solve the problem, this paper proposed a three-dimensional (3D)-UNET network model optimized by a 3D conditional random field (3D-CRF) to segment pulmonary nodules. On the basis of 3D-UNET, the 3D-CRF is used to optimize the sample output of the training set, so as to update the network weights in training process, reduce the model training time, and reduce the loss rate of the model. We selected 936 sets of pulmonary nodule data for the lung image database consortium and image database resource initiative (LIDC-IDRI) 1 database to train and test the model. What's more, we used clinical data from partner hospitals for additional validation. Results and conclusions: The results show that our method is accurate and effective. Particularly, it shows more significance for the optimization of the segmentation of adhesive pulmonary nodules (the juxta-pleural and juxta-vascular nodules) and ground glass pulmonary nodules (GGNs).
Identification of novel non-invasive biomarkers is critical for the early diagnosis of lung adenocarcinoma (LUAD), especially for the accurate classification of pulmonary nodule. Here, a multiplexed assay is developed on an optimized nanoparticle-based laser desorption/ionization mass spectrometry platform for the sensitive and selective detection of serum metabolic fingerprints (SMFs). Integrative SMFs based multi-modal platforms are constructed for the early detection of LUAD and the classification of pulmonary nodule. The dual modal model, metabolic fingerprints with protein tumor marker neural network (MP-NN), integrating SMFs with protein tumor marker carcinoembryonic antigen (CEA) via deep learning, shows superior performance compared with the single modal model Met-NN (p < 0.001). Based on MP-NN, the tri modal model MPI-RF integrating SMFs, tumor marker CEA, and image features via random forest demonstrates significantly higher performance than the clinical models (Mayo Clinic and Veterans Affairs) and the image artificial intelligence in pulmonary nodule classification (p < 0.001). The developed platforms would be promising tools for LUAD screening and pulmonary nodule management, paving the conceptual and practical foundation for the clinical application of omics tools.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.